Correction to: Inflammation (2018) 41(3): 959–971

https://doi.org/10.1007/s10753-018-0750-6

The original version of this article contained mistakes, and the authors would like to correct them. The correct details are given below:

Figure 4g (lower panel, group of control), overlapped with Fig. 3G (up panel, group of control). The corrected Fig. 4 is shown on the next page.

Fig. 4
figure 1

Downregulation of miR-140-5p/149 regulated chondrocyte proliferation and apoptosis by targeting FUT1. a–c after transfected with NC inhibitor, miR-140-5p inhibitor, or siFUT1, chondrocyte proliferation capability was measured by ki-67 immunofluorescence staining, EDU assay, and CCK-8 assay. d–f after transfection with miR-149 inhibitor and siFUT1 or co-transfection with miR-149 inhibitor and siFUT1, the proliferative capability of chondrocytes was examined by immunofluorescence staining, EDU, staining and CCK-8 assay. e after miR-140-5p/149 inhibitor or siFUT1 transfection, chondrocytes were stimulated by IL-1 β (10 ng/ml) for 24 h. The apoptosis rate was measured by flow cytometry analysis. f after transfection with miR-140-5p/149 inhibitor and siFUT1 or co-transfection with miR-140-5p/149 inhibitor and siFUT1, the expression of Bax, Bcl-2, cleaved caspase-3, and cleaved PARP was measured by western blot. Each bar represented mean ± SD (n = 3). *P < 0.05 vs. control

The authors wish to apologize for these unintentional errors.